p21-activated kinase inhibitors (Indiana University/University of Puerto Rico)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namep21-activated kinase inhibitors (Indiana University/University of Puerto Rico)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP21-activated kinases inhibitors
TargetsP21-activated kinases
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto Rico
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIndiana University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsLeukemia

Other Information

ATC CodeN/A
Related LinksN/A